Join Now!      Login

Whole Person Wellness Program Wellness Model
Skip Navigation Links
Health Centers
Key Services
Breast Cancer?
More than three-quarters of women who get breast cancer are over whtat age?
over 40 years
over 45 years
over 50 years
over 55 years


 Herceptin: more hype than hope 
The following is one in an ongoing series of columns entitled What Doctors Don't Tell You by . View all columns in series
Herceptin was supposed to be the miracle cure for breast cancer. Women have been willing to sell their houses in order to get hold of this vastly expensive drug. But behind the hype, the statistics tell another story. Herceptin kills more than cures and certainly fares poorly against a natural competitor: mistletoe.

The champagne corks were popping in Switzerland on 9 June, when the National Institute for Health and Clinical Excellence (NICE), the official British drug appraisal agency, announced that Herceptin (trastuzumab) would soon be approved for use in early-stage breast cancer. For Swiss pharmaceutical giant Roche, the incorporation of Herceptin into the British NHS system will be the final crowning glory of one of the most successful marketing campaigns in medical history.

In 1998, Roche bought the international marketing rights to Herceptin from the drug's US manufacturer, Genentech. Over the last eight years, the orchestration of their joint public relations has been masterful-with newspaper headlines of a "wonder drug","a breakthrough treatment" and even a "cure", and stories of people so desperate to get hold of Herceptin that they'll sell the roof over their head to pay for it, and High Court battles to get the drug prescribed on the NHS.

How does it work?
So what's so special about Herceptin; what's all the fuss about? The headlines have got it right in one respect. Herceptin is indeed a breakthrough in chemotherapy, but it could be argued that it's about time we had one. The vast majority of chemo drugs are simply poisons, whose mode of action is to try and kill cancer cells before killing the rest of the healthy cells in the patient. Hardly 21st-century medicine.

Herceptin is different from a poison in that it's claimed to specifically target breast cancer cells, by blocking some of the chemical signals they need in order to grow. There's good evidence that some cancers, breast cancer in particular, are related to a gene called HER2. The term HER has nothing to do with the female gender; it stands for Human Epidermal growth factor Receptor, with the 2 meaning it's the second one to be discovered.

Some breast cancers have been found to be correlated with an abnormally high level of HER2 genes in the body. When that happens, the gene "orders" an excess production of receptors on the surface of cancer cells. The receptors are the "ears" of the cell, picking up chemical signals from the rest of the body, and adjusting the cell's growth accordingly. However, if there are too many receptors, as is the case in some breast cancers, the cells pick up too many growth signals, and start to multiply uncontrollably.

Herceptin works by attaching itself to the receptor "ears", thus effectively blocking them up, and preventing the chemical "grow" signals from getting through. Roche's marketing has stressed that, because Herceptin only attaches itself to HER2 breast cancer cells, it can't theoretically affect other cells in the body. Thus it's a true "breakthrough" in chemotherapy.

Targets other cells
So far so good. The problem, though, is that in practice Herceptin is not that specific. It turns out that other receptors besides breast cancer cells can get blocked by the drug. So far, the receptors that have been found to be damaged are those in the heart and lungs. Researchers at the prestigious Salk Institute have shown that Herceptin damages a gene called erbB2, which is intimately connected with heart and lung function. Interference with this gene can cause breathing problems, and damage heart muscle to the extent of actually compromising the pumping action, leading to heart failure (Recent Prog Horm Res, 2004; 59: 1-12).

   CONTINUED    1  2  3  4  5  Next   
 Comments Add your comment 

 About The Author
What Doctors Don’t Tell You is one of the few publications in the world that can justifiably claim to solve people's health problems - and even save lives. Our monthly newsletter gives you the facts you won't......moreWhat Doctors Don't Tell You
 From Our Friends
Popular & Related Products
Popular & Featured Events
2019 National Wellness Conference
     October 1-3, 2019
     Kissimmee, FL USA
Additional Calendar Links
Dimensions of Wellness
Wellness, Thinking, dimension!

Home       Wellness       Health A-Z       Alternative Therapies       Wellness Inventory       Wellness Center
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Nutrition Center       Fitness Center
Discount Lab Tests      First Aid      Global Health Calendar      Privacy Policy     Contact Us
Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.
Are you ready to embark on a personal wellness journey with our whole person approach?
Learn More/Subscribe
Are you looking to create or enhance a culture of wellness in your organization?
Learn More
Do you want to become a wellness coach?
Learn More
Free Webinar